Premium
Central‐Nervous‐System Stimulants: Appraisal of Use in Geropsychiatric Patients
Author(s) -
CROOK THOMAS
Publication year - 1979
Publication title -
journal of the american geriatrics society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.992
H-Index - 232
eISSN - 1532-5415
pISSN - 0002-8614
DOI - 10.1111/j.1532-5415.1979.tb01731.x
Subject(s) - medicine , methylphenidate , psychiatry , pentylenetetrazol , intensive care medicine , epilepsy , attention deficit hyperactivity disorder , anticonvulsant
CNS stimulants such as methylphenidate and pentylenetetrazol are currently prescribed for the treatment of aged persons with symptoms of senility. A review of clinical studies conducted with these compounds indicates that firm evidence of efficacy is lacking. Because of the risks associated with high doses of such stimulants in the aged, it would seem that these compounds are of limited utility in geriatric psychiatry.